Momentum Stocks : Biogen Idec Inc. (NASDAQ:BIIB), Texas Instruments Inc. (NASDAQ:TXN), Brookfield Property Partners L.P. (NYSE:BPY), Virtus Investment Partners, Inc. (NASDAQ:VRTS), STZ

Concerns about the potential side effects of Biogen Idec Inc. (NASDAQ:BIIB)’s key multiple-sclerosis pill Tecfidera overshadowed the strong third-quarter results the biotech company Tecfidera is an essential part of Biogen’s goal to become the dominant maker of multiple-sclerosis treatments, a group of drugs that command high prices and that patients typically take for years. Tecfidera’s sales in the third quarter more than doubled to $787.1 million, up from $286.4 million a year earlier. Tysabri, meanwhile, posted a 25% increase in sales. . Biogen Idec Inc. (NASDAQ:BIIB) belongs to Healthcare sector. Its net profit margin is 25.60% and weekly performance is 1.11%. On last trading day company shares ended up $309.07. Biogen Idec Inc. (NASDAQ:BIIB) distance from 50-day simple moving average (SMA50) is -6.08%.

On Oct 20, Texas Instruments Inc. (NASDAQ:TXN) posted third-quarter results above expectations and its CFO said business was healthy, in contrast to recent concerns on Wall Street about a possible slowdown in chip demand. The company reported quarterly revenue of $3.50 billion, up 8 percent from the year-ago period. It forecast fourth-quarter revenue of $3.13 billion to $3.39 billion. The mid-point of TI’s revenue guidance is about $26 billion. Texas Instruments Inc. (NASDAQ:TXN) shares moved down -0.32% in last trading session and ended the day at $46.62. TXN Gross Margin is 55.00% and its return on assets is 12.10%. Texas Instruments Inc. (NASDAQ:TXN) quarterly performance is -2.59%.

Brookfield Property Partners L.P. (NYSE:BPY), said it plans to reopen the property as it expands its investments in gambling venues. Brookfield Wednesday said it won the bankrupt casino property with a $110 million bid in an auction that ended at 5:30 a.m. New York time. On 22 October, Brookfield Property Partners L.P. (NYSE:BPY) shares moved down -0.46% and was closed at $21.70. BPY EPS growth in last 5 year was 0.00%. Brookfield Property Partners L.P. (NYSE:BPY) year to date (YTD) performance is 12.90%.

Zacks lowered shares of Virtus Investment Partners (NASDAQ:VRTS) from a neutral rating to an underperform rating in a report released on Thursday. Zacks currently has $165.60 price objective on the stock. Virtus Investment Partners, Inc. (NASDAQ:VRTS) ended the last trading day at $168.86. Company weekly volatility is calculated as 5.39% and price to cash ratio as 8.43. Virtus Investment Partners, Inc. (NASDAQ:VRTS) showed a weekly performance of 0.78%.

On OCT. 20, Constellation Brands Inc. (NYSE:STZ), announced that it priced the public offering of $800 million aggregate principal amount of Senior Notes, consisting of $400 million of 3.875% Senior Notes due 2019 and $400 million of 4.750% Senior Notes due 2024 (collectively, the “notes”). Constellation Brands Inc. (NYSE:STZ) shares advanced 0.29% in last trading session and ended the day at $86.91. STZ Gross Margin is 43.20% and its return on assets is 5.30%. Constellation Brands Inc. (NYSE:STZ) quarterly performance is -0.39%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone